Financials
- Market Capitalization 36.3476 M
- Employee 89
- Founded 2012
- CEO N/A
- Website www.omniab.com
- Headquarter Delaware, United States
- FIGI BBG012QXTPF0
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.21
売上高対価格比率
0.24
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4372 | ALGS Aligos Therapeutics, Inc. - Common stock | 5.86 USD | -15.20% | -15.44% | +36.60% | -40.14% | 36.55 M USD | ||
| 4374 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.52 USD | -8.43% | +22.58% | +33.33% | -62.75% | 36.50 M USD | ||
| 4382 | CNTX Context Therapeutics Inc. - Common Stock | 0.39 USD | +2.63% | -17.02% | -37.10% | -54.12% | 35.83 M USD | ||
| 4386 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.10 USD | -3.67% | -23.36% | -53.54% | -77.91% | 35.55 M USD |